Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-09-01 Sale |
2022-09-02 4:22 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
2,500 | $60.3 | $150,750 | 104,884 (Direct) |
View |
| 2022-08-17 Sale |
2022-08-18 4:02 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $69.5 | $347,500 | 29,250 (Direct) |
View |
| 2022-08-15 Sale |
2022-08-16 5:04 pm |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
12,500 | $69 | $862,500 | 370,407 (Direct) |
View |
| 2022-08-15 Sale |
2022-08-16 5:00 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $67.21 | $84,012 | 794,253 (Indirect Direct) |
View |
| 2022-08-11 Sale |
2022-08-12 5:01 pm |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
12,500 | $67 | $837,500 | 382,907 (Direct) |
View |
| 2022-08-11 Sale |
2022-08-12 4:58 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $67 | $335,000 | 34,250 (Direct) |
View |
| 2022-08-11 Sale |
2022-08-12 4:57 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
30,000 | $65.63 | $1,968,900 | 388,264 (Indirect Direct) |
View |
| 2022-08-08 Sale |
2022-08-09 5:22 pm |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
12,500 | $65 | $812,500 | 395,407 (Direct) |
View |
| 2022-08-08 Sale |
2022-08-09 5:18 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
12,000 | $62.5 | $750,000 | 1,220,774 (Direct) |
View |
| 2022-08-08 Sale |
2022-08-09 5:16 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $64.5 | $322,500 | 39,250 (Direct) |
View |
| 2022-08-04 Sale |
2022-08-08 4:02 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
10,000 | $60.75 | $607,500 | 44,250 (Direct) |
View |
| 2022-08-03 Sale |
2022-08-04 6:40 pm |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $56.43 | $282,150 | 407,907 (Direct) |
View |
| 2022-08-01 Sale |
2022-08-02 4:18 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
2,500 | $55.99 | $139,975 | 107,384 (Direct) |
View |
| 2022-07-27 Sale |
2022-07-28 4:03 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $57 | $285,000 | 54,250 (Direct) |
View |
| 2022-07-19 Sale |
2022-07-21 4:31 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $56.42 | $282,100 | 59,250 (Direct) |
View |
| 2022-07-15 Sale |
2022-07-18 5:29 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $46.33 | $57,913 | 795,503 (Indirect Direct) |
View |
| 2022-07-11 Sale |
2022-07-12 5:55 pm |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $48.42 | $242,100 | 414,782 (Direct) |
View |
| 2022-07-08 Sale |
2022-07-12 4:04 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
12,000 | $47.95 | $575,400 | 1,534,268 (Direct) |
View |
| 2022-06-27 Sale |
2022-06-29 4:18 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
1,341 | $46.79 | $62,743 | 287,022 (Indirect) |
View |
| 2022-06-23 Sale |
2022-06-24 5:15 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
15,000 | $45 | $675,000 | 285,679 (Indirect) |
View |
| 2022-06-22 Sale |
2022-06-23 4:22 pm |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
10,000 | $44.51 | $445,140 | 125,569 (Indirect Direct) |
View |
| 2022-06-17 Sale |
2022-06-22 4:26 pm |
Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead |
2,698 | $45 | $121,410 | 24,974 (Direct) |
View |
| 2022-06-16 Sale |
2022-06-21 4:11 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
10,000 | $41.78 | $417,850 | 49,250 (Direct) |
View |
| 2022-06-15 Sale |
2022-06-17 5:02 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $39.29 | $49,113 | 796,753 (Indirect Direct) |
View |
| 2022-06-08 Sale |
2022-06-09 5:23 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
12,000 | $44.09 | $529,080 | 1,597,773 (Direct) |
View |
| 2022-06-01 Sale |
2022-06-02 6:24 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
2,500 | $41.78 | $104,450 | 109,561 (Direct) |
View |
| 2022-05-27 Sale |
2022-05-31 4:30 pm |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
10,000 | $43 | $430,000 | 42,233 (Direct) |
View |
| 2022-05-16 Sale |
2022-05-17 5:26 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $39.18 | $48,975 | 798,003 (Indirect Direct) |
View |
| 2022-05-02 Sale |
2022-05-03 7:56 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
2,500 | $43.56 | $108,900 | 113,936 (Direct) |
View |
| 2022-04-29 Sale |
2022-05-02 8:05 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
4,000 | $44.43 | $177,720 | 1,258,649 (Direct) |
View |
| 2022-04-25 Sale |
2022-04-27 4:39 pm |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
5,000 | $50 | $250,000 | 137,444 (Indirect Direct) |
View |
| 2022-04-20 Sale |
2022-04-22 5:35 pm |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
7,000 | $52.53 | $367,710 | 63,481 (Direct) |
View |
| 2022-04-14 Sale |
2022-04-18 7:42 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $50.9 | $63,625 | 799,253 (Indirect Direct) |
View |
| 2022-04-05 Sale |
2022-04-06 4:10 pm |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
609 | $60.09 | $36,593 | 101,624 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-08-30 Tax Withholding |
2022-08-31 4:26 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer |
558 | $58.84 | 18,581 (Direct) |
View |
| 2022-08-25 Exercise |
2022-08-26 4:06 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
4,306 | $13.19 | 431,238 (Direct) |
View |
| 2022-08-25 Exercise |
2022-08-26 4:06 pm |
N/A 2028-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
4,306 | $0 | 431,238 (Direct) |
View |
| 2022-08-17 Exercise |
2022-08-18 4:02 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $0 | 29,250 (Direct) |
View |
| 2022-08-17 Exercise |
2022-08-18 4:02 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $15.52 | 29,250 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-17 5:08 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
25,394 | $14 | 413,658 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-17 5:08 pm |
N/A 2027-11-08 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
25,394 | $0 | 413,658 (Direct) |
View |
| 2022-08-15 Exercise |
2022-08-16 5:04 pm |
N/A 2028-11-15 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
12,500 | $0 | 370,407 (Direct) |
View |
| 2022-08-15 Exercise |
2022-08-16 5:04 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
12,500 | $15.09 | 370,407 (Direct) |
View |
| 2022-08-15 Exercise |
2022-08-16 5:00 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 794,253 (Direct) |
View |
| 2022-08-15 Exercise |
2022-08-16 5:00 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 794,253 (Direct) |
View |
| 2022-08-11 Exercise |
2022-08-12 5:01 pm |
N/A 2028-11-15 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
12,500 | $0 | 382,907 (Direct) |
View |
| 2022-08-11 Exercise |
2022-08-12 5:01 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
12,500 | $15.09 | 382,907 (Direct) |
View |
| 2022-08-11 Exercise |
2022-08-12 4:58 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $0 | 34,250 (Direct) |
View |
| 2022-08-11 Exercise |
2022-08-12 4:58 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $15.52 | 34,250 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-09 5:22 pm |
N/A 2028-11-15 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
12,500 | $0 | 395,407 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-09 5:22 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
12,500 | $15.09 | 395,407 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-09 5:18 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $0 | 1,220,774 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-09 5:18 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $2.67 | 1,220,774 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-09 5:16 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $0 | 39,250 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-09 5:16 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $15.52 | 39,250 (Direct) |
View |
| 2022-08-04 Exercise |
2022-08-08 4:02 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
10,000 | $0 | 44,250 (Direct) |
View |
| 2022-08-04 Exercise |
2022-08-08 4:02 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
10,000 | $15.52 | 44,250 (Direct) |
View |
| 2022-08-03 Exercise |
2022-08-04 6:40 pm |
N/A 2028-11-15 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $0 | 407,907 (Direct) |
View |
| 2022-08-03 Exercise |
2022-08-04 6:40 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $15.09 | 407,907 (Direct) |
View |
| 2022-07-27 Exercise |
2022-07-28 4:03 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $0 | 54,250 (Direct) |
View |
| 2022-07-27 Exercise |
2022-07-28 4:03 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $15.52 | 54,250 (Direct) |
View |
| 2022-07-21 Exercise |
2022-07-22 4:01 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
9,606 | $14 | 443,658 (Direct) |
View |
| 2022-07-21 Exercise |
2022-07-22 4:01 pm |
N/A 2027-11-08 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
9,606 | $0 | 443,658 (Direct) |
View |
| 2022-07-19 Exercise |
2022-07-21 4:31 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $0 | 59,250 (Direct) |
View |
| 2022-07-19 Exercise |
2022-07-21 4:31 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
5,000 | $15.52 | 59,250 (Direct) |
View |
| 2022-07-15 Exercise |
2022-07-18 5:29 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 795,503 (Direct) |
View |
| 2022-07-15 Exercise |
2022-07-18 5:29 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 795,503 (Direct) |
View |
| 2022-07-11 Exercise |
2022-07-12 5:55 pm |
N/A 2028-11-15 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $0 | 414,782 (Direct) |
View |
| 2022-04-21 Other |
2022-07-12 5:55 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
13,125 | $0 | 414,782 (Direct) |
View |
| 2022-07-11 Exercise |
2022-07-12 5:55 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
5,000 | $15.09 | 414,782 (Direct) |
View |
| 2022-07-08 Exercise |
2022-07-12 4:04 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $0 | 1,534,268 (Direct) |
View |
| 2022-07-08 Exercise |
2022-07-12 4:04 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $2.67 | 1,534,268 (Direct) |
View |
| 2022-06-17 Exercise |
2022-06-22 4:32 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
33,005 | $0 | 1,244,774 (Direct) |
View |
| 2022-06-17 Exercise |
2022-06-22 4:32 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
33,005 | $2.67 | 1,244,774 (Direct) |
View |
| 2022-06-16 Exercise |
2022-06-21 4:11 pm |
N/A 2029-02-27 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
10,000 | $0 | 49,250 (Direct) |
View |
| 2022-06-16 Exercise |
2022-06-21 4:11 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
10,000 | $13.85 | 49,250 (Direct) |
View |
| 2022-06-15 Exercise |
2022-06-17 5:02 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 796,753 (Direct) |
View |
| 2022-06-15 Exercise |
2022-06-17 5:02 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 796,753 (Direct) |
View |
| 2022-06-08 Exercise |
2022-06-09 5:23 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $0 | 1,597,773 (Direct) |
View |
| 2022-06-08 Exercise |
2022-06-09 5:23 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
18,500 | $2.67 | 1,597,773 (Direct) |
View |
| 2022-04-21 Other |
2022-05-31 4:30 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
13,125 | $0 | 42,233 (Direct) |
View |
| 2022-05-16 Exercise |
2022-05-17 5:26 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 798,003 (Direct) |
View |
| 2022-05-16 Exercise |
2022-05-17 5:26 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 798,003 (Direct) |
View |
| 2022-04-21 Other |
2022-05-03 7:56 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
13,125 | $0 | 113,936 (Direct) |
View |
| 2022-04-29 Exercise |
2022-05-02 8:05 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
4,000 | $0 | 1,258,649 (Direct) |
View |
| 2022-04-21 Other |
2022-05-02 8:05 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
13,125 | $0 | 1,258,649 (Direct) |
View |
| 2022-04-29 Exercise |
2022-05-02 8:05 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
4,000 | $2.67 | 1,258,649 (Direct) |
View |
| 2022-04-21 Other |
2022-04-27 4:39 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
13,125 | $0 | 137,444 (Direct) |
View |
| 2022-04-22 Exercise |
2022-04-25 9:35 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
20,000 | $14 | 458,658 (Direct) |
View |
| 2022-04-22 Exercise |
2022-04-25 9:35 pm |
N/A 2027-11-08 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
20,000 | $0 | 458,658 (Direct) |
View |
| 2022-04-20 Exercise |
2022-04-22 5:35 pm |
N/A 2028-02-04 |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
7,000 | $0 | 63,481 (Direct) |
View |
| 2022-04-20 Exercise |
2022-04-22 5:35 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
7,000 | $15.52 | 63,481 (Direct) |
View |
| 2022-04-14 Exercise |
2022-04-18 7:42 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $0 | 799,253 (Direct) |
View |
| 2022-04-14 Exercise |
2022-04-18 7:42 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
1,250 | $2.67 | 799,253 (Direct) |
View |
| 2022-04-05 Exercise |
2022-04-06 4:10 pm |
N/A 2029-02-07 |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
609 | $0 | 101,624 (Direct) |
View |
| 2022-04-05 Exercise |
2022-04-06 4:10 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
609 | $13.85 | 101,624 (Direct) |
View |